Tyrosine kinase inhibitor with HER2/NEU receptor inhibition propey?: (A) Imatinib, (B) Nilotinib, (C) Lapatinib, (D) Sunitinib
Answer is C. Lapatinib has both the actions and active against breast cancer cells it is an EGFR inhibitor. Ref: KK Sharma 3rd ed. Pg: 870